Literature DB >> 16450128

Rational evaluation of urinary stone disease.

Albrecht Hesse1, Michael Straub.   

Abstract

This article outlines the recent state of the art in the metabolic diagnosis of stone disease. The current literature in the field of urolithiasis-including the existing German and EAU-Guidelines as well as the Conference Book of the 1st International Consultation on Stone Disease-was critically reviewed. As far as possible the references were rated according to the EBM criteria. The occurrence of stone disease in the western world is increasing greatly. Modern lifestyle, dietary habits and excess weight-problems of affluent societies-are emerging as the important promoters of the "stone boom" in the new millennium. This even affects children, whose stone prevalence is otherwise significantly less than that of adults. Criteria for the high-risk group of stone formers were clearly defined. A diagnostic standard is formulated for the basic and the elaborate metabolic evaluation of a stone patient. The diagnostic pathways for the most important stone types and metabolic disorders, respectively, are described. The present concept allows a precise risk classification of each stone former and facilitates the decision whether stone-specific measures in addition to the basic metaphylaxis are recommendable or not.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16450128     DOI: 10.1007/s00240-005-0024-2

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  17 in total

Review 1.  Drug-induced urolithiasis.

Authors:  C A Osborne; J P Lulich; J W Bartges; L K Ulrich; L A Koehler; K A Bird; L L Swanson; G W Austin; E L Prien; K U Steinam
Journal:  Vet Clin North Am Small Anim Pract       Date:  1999-01       Impact factor: 2.093

Review 2.  Guidelines on urolithiasis.

Authors:  H G Tiselius; D Ackermann; P Alken; C Buck; P Conort; M Gallucci
Journal:  Eur Urol       Date:  2001-10       Impact factor: 20.096

3.  Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000.

Authors:  A Hesse; E Brändle; D Wilbert; K-U Köhrmann; P Alken
Journal:  Eur Urol       Date:  2003-12       Impact factor: 20.096

4.  Quality control in urinary stone analysis: results of 44 ring trials (1980-2001).

Authors:  Albrecht Hesse; Rolf Kruse; Wolf-Jochen Geilenkeuser; Matthias Schmidt
Journal:  Clin Chem Lab Med       Date:  2005       Impact factor: 3.694

5.  Time trends in reported prevalence of kidney stones in the United States: 1976-1994.

Authors:  Kiriaki K Stamatelou; Mildred E Francis; Camille A Jones; Leroy M Nyberg; Gary C Curhan
Journal:  Kidney Int       Date:  2003-05       Impact factor: 10.612

6.  Intestinal hyperabsorption of oxalate in calcium oxalate stone formers: application of a new test with [13C2]oxalate.

Authors:  A Hesse; W Schneeberger; S Engfeld; G E Von Unruh; T Sauerbruch
Journal:  J Am Soc Nephrol       Date:  1999-11       Impact factor: 10.121

7.  [Roentgen examinations as standardized urinary calculi structure analysis in the German Democratic Republic (experience from 3500 urinary calculi analyses)].

Authors:  H J Schneider; A Hesse; E Hienzsch; J Tscharnke; P Schweder
Journal:  Z Urol Nephrol       Date:  1974-02

8.  2,8-Dihydroxyadeninuria: laboratory diagnosis and therapy control.

Authors:  A Hesse; W D Miersch; A Classen; A Thon; W Doppler
Journal:  Urol Int       Date:  1988       Impact factor: 2.089

9.  Reference range for gastrointestinal oxalate absorption measured with a standardized [13C2]oxalate absorption test.

Authors:  Gerd E von Unruh; Susanne Voss; Tilman Sauerbruch; Albrecht Hesse
Journal:  J Urol       Date:  2003-02       Impact factor: 7.450

10.  Dependence of oxalate absorption on the daily calcium intake.

Authors:  Gerd E von Unruh; Susanne Voss; Tilman Sauerbruch; Albrecht Hesse
Journal:  J Am Soc Nephrol       Date:  2004-06       Impact factor: 10.121

View more
  4 in total

1.  Medication-based urolithiasis and atazanavir.

Authors:  Paul M Koblic; Wayne L Gold; Charles J L la Porte; Todd C Lee
Journal:  CMAJ       Date:  2011-03-28       Impact factor: 8.262

2.  [What kind of stone prevention for whom? Risk-adjusted metaphylaxis following urinary stone disease].

Authors:  M Straub
Journal:  Urologe A       Date:  2006-11       Impact factor: 0.639

Review 3.  HIV medication-based urolithiasis.

Authors:  Hassane Izzedine; François Xavier Lescure; Fabrice Bonnet
Journal:  Clin Kidney J       Date:  2014-03-11

4.  Evaluation of children with urolithiasis.

Authors:  Syed A H Rizvi; Sajid Sultan; Mirza N Zafar; Bashir Ahmed; Syed M Faiq; Kehkashan Z Hossain; Syed A A Naqvi
Journal:  Indian J Urol       Date:  2007-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.